ProPhase Labs, Inc.
PRPHCIK 0000868278
Revenue (TTM)
$4.98M
−35.8% YoY
FY May 2026
Net Income (TTM)
−$13.93M
+72.4% YoY
FY May 2026
EPS Diluted (TTM)
−$0.51
+93.5% YoY
FY May 2026
Gross Margin
27.2%
FY May 2026
Operating Margin
-377.8%
FY May 2026
Net Margin
-279.9%
FY May 2026
Free Cash Flow (TTM)
$11.9M
FY May 2026
Cash
$90K
FY May 2026
Total Debt
$5.37M
FY May 2026
Shares Outstanding
14.02M sh
FY May 2026